Organigram (NASDAQ:OGI) Releases Earnings Results, Misses Expectations By $0.02 EPS

Organigram (NASDAQ:OGI - Get Free Report) announced its earnings results on Tuesday. The company reported ($0.05) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.02), Zacks reports. Organigram had a negative net margin of 28.58% and a negative return on equity of 11.68%.

Organigram Trading Down 4.8 %

Shares of NASDAQ:OGI traded down $0.07 during trading on Friday, hitting $1.29. 1,779,050 shares of the company were exchanged, compared to its average volume of 877,104. The stock has a market cap of $162.12 million, a price-to-earnings ratio of -3.38 and a beta of 1.00. Organigram has a fifty-two week low of $1.27 and a fifty-two week high of $2.91. The firm has a fifty day moving average price of $1.56 and a two-hundred day moving average price of $1.66.

About Organigram

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.